Flutter Over Debut Of Glenmark's Favipiravir For COVID-19 In India

Poised For Scale-Up Using In-House Capabilities

 
• By Anju Ghangurde
Coronavirus COVID-19 medical test vaccine research and development concept. Scientist in laboratory study and analyze scientific sample of Coronavirus antibody to produce drug treatment for COVID-19.
Favipiravir Gets India Green Light After Accelerated Approval • Source: Shutterstock

More from India

More from Focus On Asia